Patients with type 2 diabetes can enjoy lower blood pressure and possibly other positive effects from taking ACE inhibitor drugs, according to one study. Conducted by Italian researchers, the study was published in the Journal of the American Society of Nephrology. Researchers studied blood pressure and kidney health in a group of more than 1,100 diabetic adults. Those patients in the study who were prescribed the ACE inhibitor drug trandolapril not only benefited from lower systolic blood pressure, but also exhibited reduced levels of the protein albumin in the urine, a key indicator of diabetic kidney disease. Research is ongoing on the study group and will be released as it becomes available.